Performance-Enhancing Drugs on the Web: A Growing Public-Health Issue
Article first published online: 1 FEB 2013
Copyright © American Academy of Addiction Psychiatry
The American Journal on Addictions
Volume 22, Issue 2, pages 158–161, March-April 2013
How to Cite
Brennan, B. P., Kanayama, G. and Pope, H. G. (2013), Performance-Enhancing Drugs on the Web: A Growing Public-Health Issue. The American Journal on Addictions, 22: 158–161. doi: 10.1111/j.1521-0391.2013.00311.x
- Issue published online: 15 FEB 2013
- Article first published online: 1 FEB 2013
- Manuscript Accepted: 23 MAR 2012
- Manuscript Revised: 10 MAR 2012
- Manuscript Received: 3 FEB 2012
Background and Objectives
Today's Internet provides extensive “underground” guidelines for obtaining and using illicit substances, including especially anabolic-androgenic steroids (AAS) and other appearance- and performance-enhancing drugs (APEDs). We attempted to qualitatively characterize APED-related Internet sites.
We used relevant Internet search terms (eg, “steroids bodybuilding” and “buy steroids online”) to assess (i) the numbers of site visitors; (ii) offers of drugs for sale; and (iii) the quality of online medical information. We also chose the examples of (iv) “site-enhancing oils” and (v) “cattle implants” to illustrate the volume of available Internet information as compared with that in the medical literature.
We found thousands of sites involving AAS and other APEDs. Most sites presented an unabashedly pro-drug position, often openly questioning the qualifications and motivations of mainstream medical practitioners. Offers of AAS and other APEDs for sale, together with medical advice of varying legitimacy, was widespread across sites. Importantly, many sites provided detailed guidelines for exotic forms of APED use, some likely associated with serious health risks, which are probably unknown to most practicing clinicians.
Conclusions and Scientific Significance
It seems important for practitioners to be aware of the extent of this “underground literature,” which may strongly influence their patients' decisions about use and abuse of APEDs. (Am J Addict 2013;22:158-161)